Evidence map›Paper›PMID 42640252›Full record

ArticleThe Journal of cell biology2026

Cell cycle-dependent translation-mediated turnover of the long noncoding RNA Malat1.

Leah M Plasek-Hegde, Yeolhoe Kim, Rahul V Gupta, Emily A Dangelmaier, Sigrid Nachtergaele, Nadya Dimitrova

Abstract read
In one paragraph

Article in The Journal of cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Leah M Plasek-HegdeDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0002-0161-3277
Yeolhoe KimDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0003-2832-2493
Rahul V GuptaDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0002-0965-0398
Emily A DangelmaierDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0002-4698-2500
Sigrid NachtergaeleDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0003-0231-580X
Nadya DimitrovaDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT, USA.ORCID 0000-0002-5983-1496

Funding

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Harriet M. Kluger · 2015 to 2026
$31.1M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007499 · NIGMS · YALE UNIVERSITY · PI CARLSON, JOHN R, REINKE, VALERIE J · 1985 to 2022
$13.9M
Deregulation of long noncoding RNAs in cancerR01CA262286 · NCI · YALE UNIVERSITY · PI DIMITROVA, NADYA M · 2022 to 2025
$2.3M
Investigating the role of N6-methyladenosine in the development of drug resistance in glioblastomaF31CA306101 · NCI · YALE UNIVERSITY · PI Emily Dangelmaier · 2025 to 2026
$100k
National Research Service AwardNCI NIH HHS F31 CA306101NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA262286NIGMS NIH HHS T32 GM007499NIH HHS F31CA306101NIH HHS P50CA196530NIH HHS R01CA262286NIH HHS T32GM007499
6 · The paper itself

Abstract

Increased abundance of the nuclear long noncoding RNA (lncRNA) Malat1 drives metastatic progression and is a strong predictor of poor patient prognosis. Although the mechanism that stabilizes Malat1 through processing of its 3' terminus is well-characterized, the pathways governing its turnover remain poorly understood. Here, we show that upon exit from mitosis, Malat1 localizes to the cytoplasm, where it is degraded during early G1, resetting its abundance at the start of each cell cycle. Mechanistically, we demonstrate that Malat1 turnover is mediated by a translation- and Smg1-dependent decay pathway and triggered by redundant elements. Importantly, failure to reset Malat1 levels in early G1, due to decay inhibition or in the absence of progression through mitosis, results in Malat1 accumulation. These findings uncover a cell cycle-dependent mechanism that harnesses the translation machinery to regulate Malat1 abundance and identify cancer cell dormancy as a potential mechanism underlying the widespread overexpression of Malat1 in cancer.

Indexed as

Cell CycleProtein BiosynthesisRNA, Long NoncodingHumansMitosisRNA StabilityMALAT1 long non-coding RNA, humanRNA, Long Noncoding

Identifiers

PMID42640252
PMCPMC13505482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.